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ABSTRACT
Nanotechnology is the science and technology of small and specific things that are <100 nm in
size. Because of the size of nanomaterials, new changes in their chemical and physical structure
may occur, and indicate higher reactivity and solubility. Many of nanotechnology applications in
food and agricultural production are being developed in research and development settings.
Global challenges are related to animal production, including environmental sustainability,
human health, disease control, and food security. Nanotechnology holds promise for animal
health, veterinary medicine, and some areas of animal production. Nanotechnology has had
application in several other sectors, and its application in food and feed science is a recent case.
Especially, natural nano antimicrobials obtained from different techniques such as nano-propolis
are useful to veterinary medicine in terms of health, performance, and reliable food production.
Nano-propolis is a nano-sized (1–100nm in diameter) propolis particles tied together to make it
more effective without changing its properties by changing the size of propolis by different
methods. Propolis have many advantages such as anti-inflammatory, antioxidant, anticancer and
antifungal activity, etc. The consumption of free form of propolis restricts these benefits due to
low bioavailability, low solubility, low absorption, and untargeted release. Different nanoencapsu-
lation technologies are used to obtain nano-propolis. Nano-propolis are more easily absorbed by
the body because they have a size smaller. Nano-propolis is also more effective than propolis in
terms of antibacterial and antifungal activity. This review focuses on some recent work concern-
ing the uses of nanotechnology in animal health or human health using animal models, and the
effectiveness of nanotechnology on natural supplements such as propolis used in animal nutri-
tion and animal health.
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The term ‘nano’ is derived from a Greek word meaning
‘the dwarf’ and is generally used combined with other
words such as nanometre, nanobots, nanotechnology,
etc. (Chakravarthi and Balaji 2010). Nanotechnology is
the science and technology of small things (<100 nm)
with new changes in their chemical and physical struc-
ture, and also higher reactivity and solubility
(Troncarelli et al. 2013). Stability of the substances is
increased because of their protection against oxidising
agents, other compounds or enzymes when the active
component is nanostructured (Brand~ao et al. 2011;
Troncarelli et al. 2013). Results are promising that will
permit scientists to apply processes more rapidly and
efficiently, and, maybe, at a lower risk to consumers.
However, more studies are still needed to support the
value, and the reliability of nanotechnology, while pre-
venting any damage to the environment or to human
beings (Ramırez-Mella and Hernandez-Mendo 2010).
Nanotechnology represents advances and develop-
ing technology in the molecular, atomic and macro-
molecular fields (Scott 2005; Troncarelli et al. 2013). It
offers scientific advantage with its rapid and specific
moves, besides high bioavailability, and biodegradabil-
ity properties. All these advantages have significant
effects on both production and economic losses in
livestock animals, and healthier food and feed produc-
tion. The use of nanotechnology devices for diagnosis
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of animal diseases or as animal models for the diagno-
sis of human diseases is a great accomplishment in
one health initiative (Bentolila et al. 2009; Num and
Useh 2013). Advances in nanoscience have a signifi-
cant potency to solve the problems in the animal
health field. It can solve lots of mysteries related to
animal health, reproduction, production, good hygienic
practices and maintaining of food animals. However,
the use of nanotechnology in these area is not wide-
spread [Australian Pesticides and Veterinary Medicines
Authority (APVMA 2015)].
Bee glue or propolis is a substance that is collected
by honeybees from different plant sources such as
eucalyptus, chestnut and oak. Propolis has several bio-
logical activities such as antioxidant (Gul Baykalir et al.
2016), anti-inflammatory (Funakoshi-Tago et al. 2015),
antibacterial (Seven et al. 2011), antifungal (Shokri
et al. 2017) and antiviral (Schnitzler et al. 2010), among
others. Nano-propolis that is a natural nano-material
can be useful to veterinary medicine in terms of
health, performance, and reliable food production. The
nanoparticles are more easily absorbed by the body
because they have a size smaller (Sahlan et al. 2017),
while the nano-propolis is more effective than propolis
in terms of antibacterial and antifungal activity
(Afrouzan et al. 2012).
The studies related to nanotechnology have been
on the consideration to develop improvements in
techniques of animal production, it is necessary to
enforce this knowledge for animal health. Research
focussed on human health is already done using ani-
mal models, but sufficient information is not available
about nanotechnology. The most important point that
should not be forgotten in nanotechnology studies
necessary to include ethical, environmental and food
safety factors (Ramırez-Mella and Hernandez-
Mendo 2010).
This review focusses on some recent work concern-
ing the uses of nanotechnology in animal health or
human health done using animal models, and also
effectiveness of nanotechnology on natural supple-
ments such as propolis used in the animal nutrition
and animal health.
Nanoparticles
Nanoparticles are particles with at least one dimension
smaller than 1 micron and potentially as small as
atomic and molecular length scales (0.2 nm).
Nanoparticles can have amorphous or crystalline form
and their surfaces can act as carriers for liquid droplets
or gases. To some degree, nanoparticulate matter
should be considered a distinct state of matter, in add-
ition to the solid, liquid, gaseous, and plasma states,
due to its distinct properties (large surface area and
quantum size effects). Examples of materials in crystal-
line nanoparticle form are fullerenes and carbon nano-
tubes, while traditional crystalline solid forms are
graphite and diamond (Buzea et al. 2007). In nano-
technology, nanoparticle is described as a small object
that behaves as a whole unit for its transport and
properties. Particles are further classified by diameter.
Ultrafine particles are the same as nanoparticles and
between 1 and 100 nanometres in size. Fine particles
are sized between 100 and 2500 nanometres. Coarse
particles cover a range between 2500 and 10,000
nanometres. Nanoparticle research is currently an area
of intense scientific interest owing to a great variety of
potential applications in biomedical, optical, and elec-
tronic fields (Bagheri et al. 2016).
A series of nanoparticular systems, which include
functionalised fullerenes and carbon nanotubes, iron
oxide nanoparticles, liposomes, dendrimers, polymeric
micelles, polymeric nanospheres, nanoshells, nanobins,
quantum dots, and polymer-coated nanocrystals used
to treatment of human diseases (McMillan et al. 2011;
Troncarelli et al. 2013). The small-sized nanoparticle
contains similar physiological molecules, which also
might allow it to utilise the same mechanisms of entry
across internal barriers (Troncarelli et al. 2013). On this
basis, a comprehensive study regarding the possible
use of suitably performing nanoparticles for disease
control or diagnosis and treatment of organs pro-
tected by internal barriers has been progressing in
recent years (Pietroiusti et al. 2013; Troncarelli et al.
2013). Nanostructures are outfitted with smart particles
to allow their delivery outside certain biologic barriers
such as the brain, skin, eye, mucus, blood, cellular,
extracellular matrix placenta, and subcellular organ-
elles (Troncarelli et al. 2013). Smart delivery systems
have multifunctional properties for successful marking.
In addition, they might have been pre-programmed,
time controlled, spatially targeted, self-regulated and
remotely organised (Scott 2005; Troncarelli et al. 2013).
Especially, smart delivery system is needed for drugs
used in the treatment of human and animal diseases.
One of the main problems that contribute to a low
efficiency in drug delivery is the low drug concentra-
tions to the active location and the very short drug
residence time in the cellular and anatomical location.
In recent years, smart polymeric nanodelivery systems
have shown extraordinary capability to get over many
of the anatomical and physiological barriers and
deliver drugs locally to sites of interest thus improving
therapy. The current focus in the pharmaceutical
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industry is moving towards a smart drug, which
increases the effectiveness and decreases the toxicity
(Venditti 2017).
Nanotechnology in animal health
and production
Nanotechnology has the potential to solve many mys-
teries related to animal health, production, reproduc-
tion, good hygienic practices during rearing
and maintaining of food animals. The technology
application is usable especially with livestock.
Nanotechnology is no longer a concept or theory of
the new world, but has become a new enabling tech-
nology over the years, with enormous potential to
revolutionise agriculture and livestock development
over the world. It can supply new vehicles for molecu-
lar and cellular biology, biotechnology, veterinary
physiology, reproduction and much more (Patil et al.
2009). For example, it can be used for pathogen detec-
tion, so there are several areas that nanotechnology
could be applied in the science and engineering of
agriculture, animal, and food systems (Patil et al. 2009;
Scott and Chen 2012).
Many applications of nanotechnology for food and
agricultural production are being developed in
research and development settings. Global challenges
are related to animal production, including environ-
mental sustainability, human health, disease control,
and food security. Nanotechnology holds promise for
animal health, veterinary medicine, and other areas of
animal production (Scott 2005; Kuzma 2010). Animal
production and nanotechnology are important areas
of research and development. However, there is not
yet enough common use of nanotechnology in the
market (Kuzma 2010). Therefore, careful analysis of the
potential technical, societal, and policy implications of
these emerging applications is timely. Besides, animal
welfare, safety of animal-derived products, risks to the
environment and human health, and industry consoli-
dation are among the many concerns that are likely to
be derived from biotechnology to nanotechnology.
Furthermore, for many of the newest nanotechnology
products proposed for livestock production, biotech-
nology and nanotechnology are inseparable, and the
two converge in particular products or applications. It
is important to the public as nanotechnology and live-
stock production matures (Kuzma 2010). Lately, nano-
technology has a range of potential applications for
animal production systems, including new tools to aid
animal breeding, targeted disease treatment delivery
systems, new materials for pathogen detection,
and identity preservation systems (Buyukkilic and
Konca 2010). For example, micro and nanofluidic sys-
tems are used for the mass production of embryos for
breeding; drug delivery systems able to diffuse
inaccessible parts of an animal’s body; more biologic-
ally active drug compounds; and sensors for monitor-
ing livestock health and locations (ETC Group 2004).
The development of agriculture and animal hus-
bandry are important for animal health. Therefore,
nanotechnology has become more important for vet-
erinarians. Likewise, nanotechnology has a significant
potency to solve the problems in the animal health
field (Scott 2005). Nanoparticles have been used in
treating poultry infections. Poultry is a key source of
Campylobacter infection in humans and its prevalence
in carcases is very high (Keener et al. 2004; Manuja
et al. 2012). Researchers have hypothesised about
reducing Campylobacter in vivo using polymeric nano-
particles fed to turkeys (Franklin et al. 2003; Manuja
et al. 2012). Nanoparticles consisting of a polyethylene
glycol linker, polystyrene base and a mannose target-
ing biomolecule that adheres to Escherichia coli have
been developed (Manuja et al. 2012). The particles
bind the pathogens in the gut of livestock to prevent
colonisation and growth, and are removed in
the waste. The nanoparticles could replace traditional
sub-therapeutic uses of antibiotics and reduce the
development of antibiotic-resistant bacteria. Silver
nanoparticles have been used as an additive in diets
for weanling pigs resulting in an increase in their
growth (Fondevila et al. 2009; Manuja et al. 2012).
The Cu (II)-exchanged montmorillonite nanoparticles
(MMT-Cu) have been used to investigate the effect on
growth performance, digestive function and mucosal
disaccharase activities of weaned pigs (Tong et al.
2007; Manuja et al. 2012). The potential effect has
been reported to be mediated through antimicrobial
properties of the nanoparticles. The addition of MMT-
Cu to the diet increased the average daily weight
gain, feed efficiency, and digestibility as compared
with those of the control and copper sulphate groups
(Tong et al. 2007; Manuja et al. 2012). Nano-sized min-
erals, vitamins or supplements developed for food
application in human beings can also be used for ani-
mal feed. Nano-sized additives have also been specific-
ally developed for animal feed. Nano-sized liquid
vitamin mixes are available for use in poultry and live-
stock feed (Manuja et al. 2012).
One of the important targets in livestock is to have
a good control mechanism developing new systems to
ensure early diagnosis by farmers or veterinarians. The
smart treatment delivery systems are considered in
nanotechnology, and these systems include biological
and bioactive systems such as useful feed
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supplements, drugs, nutraceuticals, and implantable
cell bioreactors (Scott 2005).
Natural products and nanotechnology has had a
developing application in several other sectors, and its
application in food and feed science is a recent case
(Jelinek et al. 1989; Manuja et al. 2012; Hamad et al.
2017). Moreover, nanotechnologies used to improve
food quality and food safety [Nanotechnology
Industries Association (NIA 2015)]. Particularly, nano-
technology has been utilised to improve finding of a
range of chemical and microbial contaminants in
feeds. Especially, feed spoilage by fungi can be a prob-
lem for feed security. It may result in heating and
mustiness, reduced palatability and the loss of nutri-
tive value (Bryden 2012). Due to poor storage condi-
tions of animal feeds, many fungi grow easily and
produce toxins causing mycotoxicosis. The economic
effects of this contamination on the agriculture sector
is enormous, because it reduced the nutritional value
of food and feedstuff, decreased animal meat produc-
tion, and toxified the users of dairy products. A nano-
composite of MgO–SiO2 has been used as an effective
adsorbing agent for removal of aflatoxin from wheat
flour (Manuja et al. 2012). Similarly, a modified mont-
morillonite nanocomposite has been used to reduce
the toxicity due to aflatoxin in feeds of broiler chicks
(Shi et al. 2006; Manuja et al. 2012).
Li et al. (2008) reported that several natural and
synthetic nanomaterials have showed powerful anti-
microbial properties through different mechanisms,
including photocatalytic production of reactive oxygen
species that damage cell components and viruses
(for example zinc oxide and titanium dioxide), compro-
mising the bacterial cell cover [for instance, silver
nanoparticles (nAg), chitosan, carbon nanotubes, car-
boxyfullerene, peptides and zinc oxide], interruption of
energy transduction [e.g. aqueous fullerene nanopar-
ticles (nC60) and nAg], and inhibition of enzyme activ-
ity and DNA synthesis (such as chitosan) (Wassel and
Khattab 2017). The use of antimicrobial nanoparticles
produced with natural actives indicates significant
safety and efficiency outcomes against bacterial infec-
tions in animals, without causing residues in animal
products, with no need for withdrawal.
Naturally, occurring chitin and certain peptides
have been long recognised for their antimicrobial
properties (Li et al. 2008). As known, inorganic arsenic
(As-III) is a common component of the Earth’s crust. It
can be introduced into drinking water sources through
different activities. The natural occurrence of inorganic
As (III) in drinking water causes significant concern
because of its marked negative effects on human
health (Zavareh et al. 2015).
Various adsorbents are being used to remove As (III)
from drinking water. Nowadays, for this purpose, the
use of nano-sized metaloxide and hydroxide adsorbents
(such as oxides/hydroxides of iron, aluminium, manga-
nese and zirconium) is effective and attractive.
Makwana et al. (2014) reported that cinnamaldehyde is
a principal ingredient of cinnamon which contains an
essential oil which is 60–75% of the total oil.
Cinnamaldehyde is one of the molecules of importance
for development as a food antimicrobial agent due to
its demonstrated activity against both Gram-positive
and Gram-negative bacteria, including organisms that
are of concern for food safety. Cinnamaldehyde is
recorded as a flavouring agent by the food and drug
administration and is permitted to be added to food
(Makwana et al. 2014). Makwana et al. (2014) informed
that cinnamaldehyde was found to be an effective anti-
microbial against Escherichia coli W1485 and Bacillus
cereus ATCC 14579 in buffer solutions. In addition,
researchers reported that the antimicrobial effect of cin-
namaldehyde rose by encapsulation in nanoliposomes.
This study showed that the potential usefulness of pro-
gressive antimicrobial glass surfaces coated with nano-
encapsulated cinnamaldehyde for active packaging of
liquid foods.
Nano-propolis in animal health
and production
Propolis (bee glue) is a substance that is an adhesive
and dark yellow to brown-coloured balsam. It is col-
lected from some parts of trees and plants such as
eucalyptus, chestnut and oak by bees and obtained by
mixing with their wax (Tatli Seven et al. 2012; Hasan
et al. 2014). It is used today in drug and personal
products. Besides, the antimicrobial action of propolis
known as a natural product is recognised worldwide
(Troncarelli et al. 2013). Propolis and nanostructured
systems which are known as antibiotics, hormones,
probiotics, prebiotics, and imunomodulators can be
used as growth promoters in animals. The use of anti-
biotics as growth promoters in animals brings out
problems associated with microbial resistance and
antibiotic residue (Fahri 2009). Propolis has also effects
antioxidative, antimutagenic, immunomodulatory, and
cytostatic properties. These effects of propolis are
associated with its structure including rich flavonoid,
terpenoid, and phenolic acid (Prytzyk et al. 2003; Tatli
Seven et al. 2009, 2012). Antioxidant, antibacterial and
antifungal properties of propolis, colligate with the
fact that several of its contents are present in food
and/or food additives, and are recognised and gener-
ally known as safe (Burdock 1998), which makes it an
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indispensable candidate as a natural preservative in
new food applications. This meets the demand for nat-
ural-based antioxidants and antimicrobials, fuelled by
the increasing user demand for natural, minimally
processed foods with traditional preservatives at no or
at very low concentrations (Han and Park 1995; Tosi
et al. 2007).
Propolis is potentially very beneficial. It was
reported that propolis has an efficacy against the
inhibitory effects of free radicals and as an antibacter-
ial (Hasan et al. 2014; Schmidt et al. 2014). Barud et al.
(2013) determined that the ethanol extract of propolis
is 70% effective at inhibiting the growth of microor-
ganisms. It was reported that propolis has antibacterial
effects. Streptococcus mutans is a bacteria that causes
dental caries. Propolis can be used as an alternative in
the prevention of dental caries reducing the number
and growth of S. mutans (Dziedzic et al. 2013). Hasan
et al. (2011) reported that propolis can be used as an
antibacterial agent for Salmonella thipymurium.
Besides, propolis is able to inhibit E. coli and
Staphylococcus aureus (Popova et al. 2013). It was
found that propolis is an active compound against the
bacteria S. aureus (Trusheva et al. 2010). The results of
the study showed a larger clear-coloured zone with an
increase in the concentration of propolis. However,
how propolis inhibited the bacteria is unknown (Hasan
et al. 2014). Sabir (2005) hypothesised that some con-
stituents in propolis could limit the bacterial enzyme
RNA polymerase ability to attach to the DNA.
Consequently, bacterial DNA replication does not
occur. At the same time, important compounds of
propolis have the ability to prevent the action of the
enzyme restrictive endonucleases that do not occur in
RNA transcription ending with disrupted cell division.
Fatoni (2008) noticed that flavonoids and tannins are
the most effective components on bacteria of propolis.
In addition, Sabir (2005) stated that the hydroxyl
group of flavonoids may be able to decrease toxic
effects of bacteria, the changing transport systems of
nutrients and structure of organic compounds.
Nano-propolis is a nano-sized (1–100 nm in diam-
eter) propolis particles which are tried to be made it
more effective without changing its properties by
changing the size of propolis by different methods.
Nano-propolis can result in better efficacy in the fields
of medical science and biology (Afrouzan et al. 2012).
Propolis does not have a good solubility in water.
Nano-propolis would raise the ability to dissolve a sub-
stance achieving better solubility compared to prop-
olis. Nano-propolis can more easily enter through the
outer membrane of bacteria in order that the active
antibacterial compounds can harm bacterial cell walls.
Nano-propolis is obtained using microencapsulation
method (Kim et al. 2008; Sahlan and Supardi 2013;
Hasan et al. 2014). Sahlan and Supardi (2013) used
encapsulation methods to obtain nano- and micro-
propolis by casein micelles to improve its handling
properties. Researchers noticed that Indonesian prop-
olis was encapsulated by casein micelle with a hom-
ogeniser following a sonication, and separated by a
micro- and ultra-filtration system, creating micro- and
nano-particles. These micro- and nano-particles exhib-
ited high flavonoid and moderate polyphenol capaci-
ties (encapsulations efficiency, 94 and 67% for
flovonoids and polyphenols, respectively). In a further
step, the size of particles was analysed by a particle size
analyser which showed that the average size was
1.3 lm and 300 nm. The morphology of particles was
analysed by transmission electron microscopy.
Researchers stated that micro- and nano-propolis might
be used as antimicrobials agents or for other purposes
in food or healthcare products (Sahlan and Supardi
2013). In a previous study, Szliszka et al. (2009) reported
that propolis had inhibition of matrix metalloprotei-
nases, anti-angiogenesis, prevention of metastasis, cell
cycle arrest, and induction of apoptosis. Besides, prop-
olis has shown no systemic toxicity or side effects upon
in vivo administration to both rats and humans.
Therefore, there is a pressing need to find new techni-
ques to increase the potential of propolis. Recent stud-
ies (Jayakumar et al. 2013; Do Nascimento et al. 2016)
reported the encapsulation of propolis extract in nano-
particulate systems. Chitosan was used to obtain nano-
particles. Elbaz et al. (2016) investigated chitosan-based
nano-in-microparticle carriers for enhanced oral
delivery and anticancer activity of propolis. In vitro cyto-
toxicity studies showed that the propolis-loaded nano-
in-microparticles induce more cytotoxic effect on
human liver cancer cells than human colorectal cancer
cells and mediated three-fold higher therapeutic effi-
ciency than free propolis. The propolis-loaded nano-in-
microparticles induce apoptosis of human liver cancer
cells and significantly decrease their number in the
proliferative.
Propolis has already been encapsulated with
different methods as in alginate microparticles, by
atomisation methods, using gelatine as encapsulant,
by the emulsification-solvent evaporation technique at
microparticules of poly (e-caprolactone) and by incorp-
oration in a b-cylodextrin (Nori et al. 2010). The results
presented in the study (Nori et al. 2010) determine
that it was possible to encapsulate propolis extract
with soy protein isolate and pectin by complex coacer-
vation process and thus to obtain it in the powder
form, free of alcohol and with possibility of release































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































926 P. TATLI SEVEN ET AL.
under controlled conditions in foods. The authors
informed that this process protects antioxidant com-
pounds such as the phenolic and flavonoids present in
the free propolis and as well as its inhibitory activity
to S. aureus. Nano-propolis is expected to supply bet-
ter antibacterial activity compared to propolis (Hasan
et al. 2014). It has been shown that nano-propolis
inhibits E. coli growth even in very small amounts
(Prasetyo et al. 2011; Hasan et al. 2012). Propolis has
an antibacterial activity by encapsulation of Bacillus
substillis (Sahlan and Supardi 2013; Hasan et al. 2014).
It was determined that propolis and nano-propolis of
Iranian origin showed different real activity against
some bacteria (S. aureus and Candida albicans)
(Afrouzan et al. 2012; Hasan et al. 2014). Hasan et al.
(2014) found that nano-propolis was more effective
bacterial activity compared to propolis against Bacilus
subtilis, S. aureus, E. coli and Salmonella sp., 206, 212,
227, and 230% respectively. Antibacterial activity of
nano-propolis was examined compared with antibiot-
ics. The same study used ampicillin to compare the
antibacterial activity as a positive control. The reason
for using ampicillin as a positive control was for a
broad-spectrum antibiotic that can inhibit both Gram-
positive and Gram-negative bacteria (Hasan et al.
2014). Researchers (Hasan et al. 2014) used the con-
centration of ampicillin at 10mg/mL. The efficacy of
nano-propolis in comparison with ampicillin (100%) for
B. subtilis, S. aureus, E. coli and Salmonella sp. was 44,
49, 42, and 38% respectively. The clear area of nano-
propolis significantly varied with ampicillin for all test
bacteria (Hasan et al. 2014). In a research using tetra-
cycline, nano-propolis was more effective against
S. aureus than tetracycline, with 20mm diameter inhib-
ition zone (Gonsales et al. 2006; Afrouzan et al. 2012).
Afrouzan et al. (2012) showed that antimicrobial activ-
ity of nano-propolis in comparison to propolis was
more effective. The inhibition zone diameters of nano-
propolis were significantly higher than propolis against
both C. albicans (p< .05) and S. aureus (p< .01).
Afrouzan et al. (2012) reported that the antimicro-
bial activity of nano-propolis was more effective
against Gram-positive bacteria than yeast. They sug-
gested that the causes for nano-propolis being more
effective in antibacterial activity than antifungal activ-
ity could be due to the characteristic of cell walls dif-
ferences present in membranes of bacteria and yeast,
the antibacterial activity, and the thickness of the pep-
tidoglycan layer (Afrouzan et al. 2012). Afrouzan et al.
(2012) showed that natural nanoparticles have the
potential to be used efficiently in the control of bac-
terial and fungal diseases. Fahri (2009) studied potency
of nano-propolis as a growth promoter using in vivo
assays on male rats. In this study, encapsulated propolis
nanoparticles that had been prepared by the high-
speed homogenisation technique followed by encapsu-
lation using maltodextrin with solvent evaporation
technique were used. The size of nano-propolis was
evaluated by scanning electron microscope. Researcher
used the body weight of rats to determine how prop-
olis affects the bacteria. It was found that the highest
effectiveness reached by nano-propolis 2%, with effect-
ivity of 109% compared to the positive control, and the
most stable count of E. coli on faecal material in nano-
propolis of 2%.
Chung et al. (2010) investigated the hypoglycaemic
effect of nano powder propolis. Streptozotocin-
induced diabetic rats were divided into two groups: a
diabetic control group and a group to which nano
powder propolis (0.9mL) was administered. After the
rats were fed with nano-propolis for 4 weeks, an oral
glucose tolerance test was made, and then blood
sugar, blood lipid levels and body weights were meas-
ured after 16 h fasting. Chung et al. (2010) determined
that the nano-propolis was effective in the treatment
of diabetes because of the reduction of blood sugar
level and the regeneration of damaged b-cells
observed in streptozotocin-induced diabetic rats.
The antibacterial effect of Chinese propolis and
nano-propolis on common pathogens in vitro was
investigated (Jingli and Feili 2008). According to the
study, while both Chinese propolis and nano-propolis
could inhibit bacteria effectively, nano-propolis
showed more effective inhibitory activity. However, it
was determined that their inhibitory effect on S. aureus
was weaker than oxacillin and vancomycin. The results
of some studies related to nano-propolis are summar-
ised in Table 1.
Conclusions
Nanotechnology is effective in almost every area of
concern to human and animal health. Nanotechnology
offers scientific advantage with its rapid and specific
moves, besides high bioavailability, and biodegradabil-
ity properties. All these advantages have significant
effects on both production and economic losses in
livestock animals and more healthy animal production.
Nanomedicines against various pathogens in veterinary
medicine could be developed. Especially, natural nano-
antimicrobials such as nano-propolis are useful to vet-
erinary medicine in terms of health, performance, and
reliable food production. There is a need to increase
research because of the paucity of research currently
being done on this topic.
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